Research Article
Identification of Potential Biomarkers and Immune Features of Sepsis Using Bioinformatics Analysis
(a) Functions enriched for the genes involved in cluster A |
| Term | Description | Count | value |
| GO:0050852 | T-cell receptor signaling pathway | 16 | | GO:0006955 | Immune response | 14 | | GO:0031295 | T-cell costimulation | 12 | | GO:0007166 | Cell surface receptor signaling pathway | 11 | | GO:0007169 | Transmembrane receptor protein tyrosine kinase signaling pathway | 8 | | GO:0050776 | Regulation of immune response | 8 | | GO:0042110 | T-cell activation | 7 | | GO:0019882 | Antigen processing and presentation | 7 | | GO:0042102 | Positive regulation of T-cell proliferation | 7 | | GO:0002504 | Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 6 | | GO:0060333 | Interferon-gamma-mediated signaling pathway | 6 | | GO:0019886 | Antigen processing and presentation of exogenous peptide antigen via MHC class II | 6 | | GO:0002250 | Adaptive immune response | 6 | | GO:0045087 | Innate immune response | 6 | 0.00105484 | hsa04660 | T-cell receptor signaling pathway | 11 | | hsa04514 | Cell adhesion molecules (CAMs) | 11 | | hsa04612 | Antigen processing and presentation | 10 | | hsa05166 | HTLV-1 infection | 10 | | hsa05332 | Graft-versus-host disease | 9 | | hsa05330 | Allograft rejection | 9 | | hsa04940 | Type I diabetes mellitus | 9 | | hsa05320 | Autoimmune thyroid disease | 9 | | hsa04640 | Hematopoietic cell lineage | 9 | | hsa05416 | Viral myocarditis | 8 | | hsa05323 | Rheumatoid arthritis | 8 | | hsa05340 | Primary immunodeficiency | 7 | | hsa04672 | Intestinal immune network for IgA production | 7 | | hsa05321 | Inflammatory bowel disease (IBD) | 7 | | hsa04650 | Natural killer cell-mediated cytotoxicity | 7 | 0.00000753 | hsa05322 | Systemic lupus erythematosus | 7 | 0.0000129 |
|
|
(b) Functions enriched for the genes involved in cluster B |
| Term | Description | Count | value |
| GO:0045087 | Innate immune response | 7 | | GO:0006508 | Proteolysis | 5 | 0.004385255 | GO:0019731 | Antibacterial humoral response | 4 | | GO:0006955 | Immune response | 4 | 0.019097644 | GO:0001878 | Response to yeast | 3 | | GO:0050829 | Defense response to Gram-negative bacterium | 3 | 0.002549924 | GO:0071347 | Cellular response to interleukin-1 | 3 | 0.004210679 | GO:0022617 | Extracellular matrix disassembly | 3 | 0.004809135 | GO:0050830 | Defense response to Gram-positive bacterium | 3 | 0.005979232 | GO:0071356 | Cellular response to tumor necrosis factor | 3 | 0.009834724 | GO:0071222 | Cellular response to lipopolysaccharide | 3 | 0.010355235 | GO:0045766 | Positive regulation of angiogenesis | 3 | 0.010708943 | GO:0042742 | Defense response to bacterium | 3 | 0.016637646 | GO:0006032 | Chitin catabolic process | 2 | 0.009550291 | GO:0009635 | Response to herbicide | 2 | 0.009550291 | GO:0019732 | Antifungal humoral response | 2 | 0.01361651 | GO:0044130 | Negative regulation of growth of symbiont in host | 2 | 0.021701096 | GO:0070207 | Protein homotrimerization | 2 | 0.029722278 | GO:0002227 | Innate immune response in mucosa | 2 | 0.033709241 | GO:0035987 | Endodermal cell differentiation | 2 | 0.036358505 | GO:0032715 | Negative regulation of interleukin-6 production | 2 | 0.03768053 | GO:0050766 | Positive regulation of phagocytosis | 2 | 0.03900082 | GO:0010043 | Response to zinc ion | 2 | 0.048194457 |
|
|